Home NDC 16571-070 Cefaclor
Product NDC 16571-070
11-digit product format 165710070
Labeler code 16571
Product ID 16571-070_309bc345-79d1-4e7a-80fc-cfafd8e1010b
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Cefaclor
Dosage form SUSPENSION
Route ORAL
Labeler Pack Pharmaceuticals, LLC
Application ANDA065412
Marketing category ANDA
Marketing start 2012-10-25
Marketing end 0000-00-00
Substance CEFACLOR
Active strength 125 mg/5mL
Pharmacologic classes Cephalosporin Antibacterial [EPC],Cephalosporins [CS]
NDC exclude flag No
Listing certified through 2019-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 36 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 16571-070-12 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 16571-070-12 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 16571-070-12 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 16571-070-12 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 16571-070-12 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 16571-070-12 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 16571-070-12 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 16571-070-12 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 16571-070-12 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 16571-070-12 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 16571-070-12 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 16571-070-12 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 16571-070-12 I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 16571-070-12 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product I Inactivated by FDA bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 16571-070-12 I Inactivated by FDA bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 16571-070-12 I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2020-12-18 03:04 UTC · source 2020-12-17 excluded product product I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 16571-070-12 I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 16571-070-12 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A065412-001 CEFACLOR CEFACLOR EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 A065412-002 CEFACLOR CEFACLOR EQ 187MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 A065412-003 CEFACLOR CEFACLOR EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 A065412-004 CEFACLOR CEFACLOR EQ 375MG BASE/5ML FOR SUSPENSION / ORAL RS 2012-02-17
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 168 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A065412-001 CEFACLOR EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A065412-002 CEFACLOR EQ 187MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A065412-003 CEFACLOR EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A065412-004 CEFACLOR EQ 375MG BASE/5ML FOR SUSPENSION / ORAL RS 2012-02-17 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A065412-001 CEFACLOR EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A065412-002 CEFACLOR EQ 187MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A065412-003 CEFACLOR EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A065412-004 CEFACLOR EQ 375MG BASE/5ML FOR SUSPENSION / ORAL RS 2012-02-17 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A065412-001 CEFACLOR EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A065412-002 CEFACLOR EQ 187MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A065412-003 CEFACLOR EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A065412-004 CEFACLOR EQ 375MG BASE/5ML FOR SUSPENSION / ORAL RS 2012-02-17 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A065412-001 CEFACLOR EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A065412-002 CEFACLOR EQ 187MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A065412-003 CEFACLOR EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A065412-004 CEFACLOR EQ 375MG BASE/5ML FOR SUSPENSION / ORAL RS 2012-02-17 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A065412-001 CEFACLOR EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A065412-002 CEFACLOR EQ 187MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A065412-003 CEFACLOR EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A065412-004 CEFACLOR EQ 375MG BASE/5ML FOR SUSPENSION / ORAL RS 2012-02-17 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A065412-001 CEFACLOR EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A065412-002 CEFACLOR EQ 187MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A065412-003 CEFACLOR EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A065412-004 CEFACLOR EQ 375MG BASE/5ML FOR SUSPENSION / ORAL RS 2012-02-17 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A065412-001 CEFACLOR EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A065412-002 CEFACLOR EQ 187MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A065412-003 CEFACLOR EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A065412-004 CEFACLOR EQ 375MG BASE/5ML FOR SUSPENSION / ORAL RS 2012-02-17 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A065412-001 CEFACLOR EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A065412-002 CEFACLOR EQ 187MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A065412-003 CEFACLOR EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A065412-004 CEFACLOR EQ 375MG BASE/5ML FOR SUSPENSION / ORAL RS 2012-02-17 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A065412-001 CEFACLOR EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A065412-002 CEFACLOR EQ 187MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A065412-003 CEFACLOR EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A065412-004 CEFACLOR EQ 375MG BASE/5ML FOR SUSPENSION / ORAL RS 2012-02-17 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A065412-001 CEFACLOR EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A065412-002 CEFACLOR EQ 187MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A065412-003 CEFACLOR EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 2012-02-17 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A065412-004 CEFACLOR EQ 375MG BASE/5ML FOR SUSPENSION / ORAL RS 2012-02-17 d8e5a09893c0…
FDA-Initiated Inactive NDC Indexing# DailyMed Socrata Ingredients# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.